Accessibility Menu
Amplify ETF Trust - Amplify Weight Loss Drug & Treatment ETF logo

Amplify ETF Trust - Amplify Weight Loss Drug & Treatment ETF(NYSEMKT) THNR

Market CapN/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2024)+4%
5 YearN/A
1 Year+15%
1 Month+1%
$25.66
-0.44%
-0.11Today
Amplify ETF Trust - Amplify Weight Loss Drug & Treatment ETF last closing stock price
MetricPriceDate
Last closeUSD 25.862026-07-30
Amplify ETF Trust - Amplify Weight Loss Drug & Treatment ETF stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0.74%USD 25.672026-07-23
1 month+0.67%USD 25.692026-06-30
3 month+5.03%USD 24.632026-05-01
Year to date+2.55%USD 25.222025-12-31
1 year+14.65%USD 22.562025-07-30
Since inception+4.11%USD 24.762024-05-21

Amplify ETF Trust - Amplify Weight Loss Drug & Treatment ETF Financials at a Glance

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

N/A

Net Income (TTM)

N/A

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.41

Beta (Volatility)

0.69 (Low)

Price

$25.66

Volume

758.913

Open

$25.64

Previous Close

$25.86

Daily Range

$25.64 - $25.86

52-Week Range

$21.70 - $27.28

Estimated Earnings Date

N/A

THNR News

Pharmacists reviewing medication

5 Best GLP-1 Stocks for 2026 and How to Invest

Rachel WarrenJun 24, 2026
Physician holding up a paper reading Diabetes.

Can You Invest in Ozempic in 2026? Everything You Need to Know

Rachel WarrenMar 26, 2026

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Amplify ETF Trust - Amplify Weight Loss Drug & Treatment ETF

Amplify Weight Loss Drug & Treatment ETF focuses on providing investors access to international firms benefiting from advancements in weight management pharmaceuticals. The ETF aims to replicate the performance of the VettaFi Weight Loss Drug & Treatment Index, offering a unique investment opportunity in a growing sector.

Products and Services
  • Investment in companies involved in weight loss pharmaceuticals
  • Access to a diversified portfolio of international firms
  • Performance tracking against the VettaFi Weight Loss Drug & Treatment Index
Growth Outlook
  • Weight management market projected to grow significantly in the coming years
  • Increased global focus on health and wellness driving demand for weight loss solutions
  • Innovations in pharmaceuticals expected to enhance market opportunities
Financial Highlights
  • Current price stands at $25.705, within a 52-week range of $21.7 to $27.28
  • Recent dividend yield of 1.61% reflects steady income potential
  • Average trading volume of 2,324 shares indicates active market interest
Amplify Weight Loss Drug & Treatment ETF positions itself in a rapidly expanding market, driven by increasing health consciousness and advancements in pharmaceutical solutions. The ETF's focus on international firms allows for a diversified investment approach, catering to a growing demand for effective weight management options. Recent financial metrics, including a solid dividend yield and active trading volume, suggest a favorable environment for potential investors. The company's strategy to mirror the performance of a specialized index further enhances its appeal in the asset management sector.
AI Generated • Jul 20, 2026

Industry

Capital Markets

Sector

Financials

Headquarters

Lisle, IL 60532, US

THNR Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

0.00%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

N/A

Dividend Yield

1.60%

Payout Ratio

N/A

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

200.00K

Volume

758.913

Avg. Volume

1.95K

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Amplify ETF Trust - Amplify Weight Loss Drug & Treatment ETF Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
CurrentYOY CHG

Revenue

N/A

N/A

Gross Profit

N/A

N/A

Gross Margin

N/A

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

N/A

N/A

Net Income

N/A

N/A

EBITDA

N/A

N/A

Quarterly Fundamentals

Name
CurrentYOY CHG

Total Cash

N/A

N/A

Total Debt

N/A

N/A

Accounts Receivable

N/A

N/A

Inventory

N/A

N/A

Long Term Debt

N/A

N/A

Short Term Debt

N/A

N/A

Return on Assets

N/A

N/A

Return on Invested Capital

N/A

N/A

Free Cash Flow

N/A

N/A

Operating Cash Flow

N/A

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CDIGCity Different Investments Global Equity ETF
$24.87+0.87%
MCHSMatthews China Discovery Active ETF MCHS
$39.55-1.24%
DUKXOcean Park International ETF
$28.15+2.28%

Trending Stocks

Symbol / CompanyPricePrice Chg
INTCIntel
$91.13+0.11%
NVDANvidia
$195.04+0.03%
MSFTMicrosoft
$451.10+0.16%
NOKNokia
$9.09+0.08%

Questions About THNR

What is the current price of Amplify ETF Trust - Amplify Weight Loss Drug & Treatment ETF?

Amplify ETF Trust - Amplify Weight Loss Drug & Treatment ETF is trading at $25.86 per share.

What is the 52-week range for Amplify ETF Trust - Amplify Weight Loss Drug & Treatment ETF?

Over the past 52 weeks, Amplify ETF Trust - Amplify Weight Loss Drug & Treatment ETF has traded between $21.70 and $27.28.

How much debt does Amplify ETF Trust - Amplify Weight Loss Drug & Treatment ETF have?

Amplify ETF Trust - Amplify Weight Loss Drug & Treatment ETF total debt is unavailable.

How much cash does Amplify ETF Trust - Amplify Weight Loss Drug & Treatment ETF have on hand?

Amplify ETF Trust - Amplify Weight Loss Drug & Treatment ETF does not have cash on hand data available.

What is Amplify ETF Trust - Amplify Weight Loss Drug & Treatment ETF’s dividend yield?

Amplify ETF Trust - Amplify Weight Loss Drug & Treatment ETF currently has a dividend yield of 1.60%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services